Minaris and Genetix Biotherapeutics Enhance Production of LYFGENIA™ for Sickle Cell Treatment Minaris and Genetix Biotherapeutics announced an expanded manufacturing partnership to significantly enhance the production of LYFGENIA™, a vital gene therapy for sickle cell disease, addressing patient needs effectively.

Minaris and Genetix Biotherapeutics Enhance Production of LYFGENIA™ for Sickle Cell Treatment #USA #Philadelphia #Minaris #LYFGENIA #Genetix

General Facts about Gene Therapy:

#LentiGlobin and #Exa-cel studies

#Casgevy #Lyfgenia #GeneTherapy #CRISPR #SickleCellDisease #Hematology #CellTherapy #ClinicalTrials
@ash.edu.hematology.org @asgct.bsky.social @cfgtedinburgh.bsky.social @genesndiseases.bsky.social
@bsochaem.bsky.social

SCD and Gene Therapy:

Additional facts about the LentiGlobin Study

#Lyfgenia #GeneTherapy #CRISPRGeneEditing #SickleCellDisease #Hematology #CellTherapy #RareDiseases #BloodDisorders #MedicalEducation #InternalMedicine

SCD and Gene Therapy:

Additional facts about the LentiGlobin Study

@asgct.bsky.social @ash.edu.hematology.org @ash.hematology.org @cuhemeonc.bsky.social @bsochaem.bsky.social #Lyfgenia #LentiGlobin #GeneTherapy #SickleCellDisease #Hematology #CellTherapy #MedicalEducation #InternalMedicine

🧬 Today’s question focuses on how #Lyfgenia differs from allogeneic #HSCT.

See the answer and explanation on the next slide!

@asgct.bsky.social @ash.edu.hematology.org @bsochaem.bsky.social @dukemedschool.bsky.social @dgsomucla.bsky.social @harvardmed.bsky.social @bcmhouston.bsky.social

SCD and Gene Therapy:

Additional facts about the LentiGlobin Study

@ash.hematology.org @asgct.bsky.social @ash.edu.hematology.org
#Lyfgenia #LentiGlobin #GeneTherapy #SickleCellDisease #Hematology #CellTherapy #ClinicalTrials #RareDiseases #BloodDisorders #StemCellTherapy

Facts about Sickle Cell Disease and Gene Therapy

Study Focus: LentiGlobin (Lovotibeglogene Autotemcel, Lyfgenia)

@ash.hematology.org @asgct.bsky.social @ash.edu.hematology.org
#Lyfgenia #GeneTherapy #SickleCellDisease #Hematology #CellTherapy #RareDiseases #BloodDisorders #MedicalEducation

Today’s question!

Check out the answer on the next slide along with its explanation.

#Lyfgenia #GeneTherapy #SickleCellDisease #Hematology #CellTherapy #RareDiseases #BloodDisorders @ash.hematology.org @rarediseasectn.bsky.social @cuhemeonc.bsky.social @ash.edu.hematology.org @asgct.bsky.social

Why might anemia persist in a patient treated with Lyfgenia despite elimination of VOCs?

See the answer and explanation on the next slide!

#Lyfgenia #LentiGlobin #GeneTherapy #SickleCellDisease #Hematology #CellTherapy #ClinicalTrials #RareDiseases #BloodDisorders #StemCellTherapy

Today’s question explores how vector copy number relates to treatment outcomes in patients receiving Lyfgenia.

Check out the answer on the next slide along with its explanation!

#Lyfgenia #GeneTherapy #SickleCellDisease #Hematology #RareDiseases #BloodDisorders #MedicalEducation

This is more than innovation — it’s equity in action.
Let’s make sure no one is left behind. ✊🏾

#SickleCellAwareness #GeneTherapy #Casgevy #Lyfgenia #HealthEquity #CRISPR #MedicaidMatters #BlackHealthMatters #FutureOfMedicine #CMS #ValueBasedCare #MedicalInnovation #ChronicIllnessWarrior

Man Cured Of Sickle Cell Anemia In New York Thanks To New Gene Therapy NY resident Sebastien Beauzile was treated with a pioneering new gene therapy approach called Lyfgenia, curing his sickle cell anemia.

"A 21 year old man in New York has been cured of #sickleCellAnemia following treatment with a pioneering #geneTherapy ,... Sebastien Beauzile was treated with a pioneering new gene therapy approach called #Lyfgenia, developed by biotech company bluebird bio ." www.forbes.com/sites/victor...

First Patient Cured of Sickle Cell Anemia - Drugs.com MedNews For 21 years, Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic treatment, he is the first person in

After 21 years with sickle cell anemia, the first New Yorker has been cured through #Lyfgenia gene therapy. The treatment modifies a patient's bone marrow to create healthy red blood cells.#SickleCell